UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Sustainability of seizure reduction and seizure control with adjunctive cenobamate: Post hoc analysis of a phase 3, open-label study

Epilepsia (Copenhagen), 2023-10, Vol.64 (10), p.2644-2652

2023

Volltextzugriff (PDF)

FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force

Epilepsia open, 2021-03, Vol.6 (1), p.45-48

2021

Volltextzugriff (PDF)

Intellectual Disability and Epilepsy: The High Incidence and the Risks of Status Epilepticus and Sudden Death Require Improved Therapies

Epilepsy currents, 2023-12, Vol.23 (6), p.354-356

Vossler, David G.

2023

Volltextzugriff (PDF)

Does SARS-CoV-2 Cause Seizures and Epilepsy in COVID-19 via Inflammation or by Direct Infection?

Epilepsy currents, 2023-05, Vol.23 (3), p.153-155

Vossler, David G.

2023

Volltextzugriff (PDF)

Remarkably High Efficacy of Cenobamate in Adults With Focal-Onset Seizures: A Double-Blind, Randomized, Placebo-Controlled Trial

Epilepsy currents, 2020-03, Vol.20 (2), p.85-87

Vossler, David G.

2020

Volltextzugriff (PDF)

Midazolam, Ketamine, and Propofol: While We Slept, Others Worked on Anesthetizing Infusions for Refractory Status Epilepticus

Epilepsy currents, 2023-07, Vol.23 (4), p.230-232

Vossler, David G.

2023

Volltextzugriff (PDF)

Ganaxolone: A New Treatment for CDKL5 Deficiency Disorder

Epilepsy currents, 2022-11, Vol.22 (6), p.348-350

Vossler, David G.

2022

Volltextzugriff (PDF)

Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial

Journal of neurology, neurosurgery and psychiatry, 2020-10, Vol.91 (10), p.1067

2020

Volltextzugriff (PDF)

Stroke and Ischemic Heart Disease With Enzyme-inducing Antiseizure Medications: Time to Change Prescribing Habits

Epilepsy currents, 2022-03, Vol.22 (2), p.120-122

Vossler, David G.

2022

Volltextzugriff (PDF)

Comparative Risk of Major Congenital Malformations With 8 Different Antiepileptic Drugs: A Prospective Cohort Study of the EURAP Registry

Epilepsy currents, 2019-03, Vol.19 (2), p.83-85

Vossler, David G.

2019

Volltextzugriff (PDF)

Diagnostic Yield and Treatment Changes After Genetic Testing of Adults With Epilepsy

Epilepsy currents, 2022-07, Vol.22 (4), p.216-218

Vossler, David G.

2022

Volltextzugriff (PDF)

Cutting-Edge Classification of Focal Cortical Dysplasia for Epilepsy Surgery

Epilepsy currents, 2022-02, Vol.22 (1), p.48-50

Vossler, David G.

2022

Volltextzugriff (PDF)

COVID-19 Incidence and Death Rate in Epilepsy: Too Early to Tell?

Epilepsy currents, 2021-07, Vol.21 (4), p.261-263

Vossler, David G.

2021

Volltextzugriff (PDF)

Forecasting Seizure Storms Using Epilepsy Wristband Sensors

Epilepsy currents, 2021-03, Vol.21 (2), p.99-101

Vossler, David G.

2021

Volltextzugriff (PDF)

The Nose Knows: Intranasal Midazolam To Treat Acute Seizures During Inpatient Epilepsy Monitoring

Epilepsy currents, 2020-11, Vol.20 (6), p.356-358

Vossler, David G.

2020

Volltextzugriff (PDF)

Brain‐responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy

Epilepsia (Copenhagen), 2017-06, Vol.58 (6), p.994-1004

2017

Volltextzugriff (PDF)

Tiagabine in clinical practice: effects on seizure control and behavior

Epilepsy & behavior, 2013-08, Vol.28 (2), p.211-216

2013

Volltextzugriff (PDF)

Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications

Epilepsia (Copenhagen), 2021-12, Vol.62 (12), p.3016-3028

2021

Volltextzugriff (PDF)

Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open‐label study

Epilepsia (Copenhagen), 2021-12, Vol.62 (12), p.3005-3015

2021

Volltextzugriff (PDF)

Is it a Tie at This Point in the Game? Efficacy of Levetiracetam and Phenytoin for the Second-Line Treatment of Convulsive Status Epilepticus

Epilepsy currents, 2019-09, Vol.19 (5), p.294-296

Vossler, David G.

2019

Volltextzugriff (PDF)

Treatment of Super-Refractory Status Epilepticus: A Review

Epilepsy Currents, 2021-11, Vol.21 (6), p.405-415

2021

Volltextzugriff (PDF)

Long‐term exposure and safety of lacosamide monotherapy for the treatment of partial‐onset (focal) seizures: Results from a multicenter, open‐label trial

Epilepsia (Copenhagen), 2016-10, Vol.57 (10), p.1625-1633

2016

Volltextzugriff (PDF)

Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee

Epilepsy currents, 2020-09, Vol.20 (5), p.245-264

2020

Volltextzugriff (PDF)

Serum sodium levels and related treatment‐emergent adverse events during eslicarbazepine acetate use in adults with epilepsy

Epilepsia (Copenhagen), 2019-07, Vol.60 (7), p.1341-1352

2019

Volltextzugriff (PDF)

Program of Active Consumer Engagement in Self‐Management in Epilepsy: Replication and extension of a self‐management randomized controlled trial

Epilepsia (Copenhagen), 2020-06, Vol.61 (6), p.1129-1141

2020

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(77)

Publikationsform

Sprache

Englisch
(83)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sustainability of seizure reduction and seizure control with adjunctive cenobamate: Post hoc analysis of a phase 3, open-label study

FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force

Intellectual Disability and Epilepsy: The High Incidence and the Risks of Status Epilepticus and Sudden Death Require Improved Therapies

Does SARS-CoV-2 Cause Seizures and Epilepsy in COVID-19 via Inflammation or by Direct Infection?

Remarkably High Efficacy of Cenobamate in Adults With Focal-Onset Seizures: A Double-Blind, Randomized, Placebo-Controlled Trial

Midazolam, Ketamine, and Propofol: While We Slept, Others Worked on Anesthetizing Infusions for Refractory Status Epilepticus

Ganaxolone: A New Treatment for CDKL5 Deficiency Disorder

Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial

Stroke and Ischemic Heart Disease With Enzyme-inducing Antiseizure Medications: Time to Change Prescribing Habits

Comparative Risk of Major Congenital Malformations With 8 Different Antiepileptic Drugs: A Prospective Cohort Study of the EURAP Registry

Diagnostic Yield and Treatment Changes After Genetic Testing of Adults With Epilepsy

Cutting-Edge Classification of Focal Cortical Dysplasia for Epilepsy Surgery

COVID-19 Incidence and Death Rate in Epilepsy: Too Early to Tell?

Forecasting Seizure Storms Using Epilepsy Wristband Sensors

The Nose Knows: Intranasal Midazolam To Treat Acute Seizures During Inpatient Epilepsy Monitoring

Brain‐responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy

Tiagabine in clinical practice: effects on seizure control and behavior

Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications

Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open‐label study

Is it a Tie at This Point in the Game? Efficacy of Levetiracetam and Phenytoin for the Second-Line Treatment of Convulsive Status Epilepticus

Treatment of Super-Refractory Status Epilepticus: A Review

Long‐term exposure and safety of lacosamide monotherapy for the treatment of partial‐onset (focal) seizures: Results from a multicenter, open‐label trial

Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee

Serum sodium levels and related treatment‐emergent adverse events during eslicarbazepine acetate use in adults with epilepsy

Program of Active Consumer Engagement in Self‐Management in Epilepsy: Replication and extension of a self‐management randomized controlled trial

Suchergebnisse filtern